<code id='73F456BA99'></code><style id='73F456BA99'></style>
    • <acronym id='73F456BA99'></acronym>
      <center id='73F456BA99'><center id='73F456BA99'><tfoot id='73F456BA99'></tfoot></center><abbr id='73F456BA99'><dir id='73F456BA99'><tfoot id='73F456BA99'></tfoot><noframes id='73F456BA99'>

    • <optgroup id='73F456BA99'><strike id='73F456BA99'><sup id='73F456BA99'></sup></strike><code id='73F456BA99'></code></optgroup>
        1. <b id='73F456BA99'><label id='73F456BA99'><select id='73F456BA99'><dt id='73F456BA99'><span id='73F456BA99'></span></dt></select></label></b><u id='73F456BA99'></u>
          <i id='73F456BA99'><strike id='73F456BA99'><tt id='73F456BA99'><pre id='73F456BA99'></pre></tt></strike></i>

          entertainment

          entertainment

          author:comprehensive    Page View:3991
          Commuters wearing face masks walk along a pedestrian bridge during the evening rush hour in Beijing -- health coverage from STAT
          Mark Schiefelbein/AP

          Northeastern University has been selected for a leading role in a new national network formed to better forecast the spread of a future pandemic.

          The university announced Tuesday the US Centers for Disease Control and Prevention has awarded it $17.5 million over the next five years to develop a center focused on detecting and preparing for the next outbreak of infectious disease, especially in rural areas.

          advertisement

          Alessandro Vespignani, director of Northeastern’s Network Science Institute, is leading the project, called “EPISTORM: The Center for Advanced Epidemic Analytics and Predictive Modeling Technology.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          Readout LOUD podcast: Pharma in Washington, Alnylam, and Gilead
          Readout LOUD podcast: Pharma in Washington, Alnylam, and Gilead

          HasPhRMAlostitsfangs?Are11th-hourchangesominousforclinicaltrials?Andwhat’snextinpainmedicine?Wecover

          read more
          Medicare details structure of new drug price negotiation program
          Medicare details structure of new drug price negotiation program

          MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

          read more

          Elevance, SCAN deals highlight health insurer acquisition scrutiny

          AdobeAdealisneverreallydoneuntilit’sdone.OnTuesday,twodifferentproposedinsuranceplanacquisitionsondi